Keros Therapeutics

Keros Therapeutics

Biotechnology Research

Lexington, Massachusetts 5,090 followers

Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.

About us

Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from rare hematologic and musculoskeletal disorders with high unmet medical need.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Lexington, Massachusetts
Type
Public Company
Founded
2016

Locations

  • Primary

    1050 Waltham St

    Suite 302

    Lexington, Massachusetts 02421, US

    Get directions

Employees at Keros Therapeutics

Updates

Similar pages

Browse jobs

Funding

Keros Therapeutics 5 total rounds

Last Round

Post IPO equity

US$ 140.0M

See more info on crunchbase